Market Research Logo

GP Pharm, S.A. - Product Pipeline Review - 2016

GP Pharm, S.A. - Product Pipeline Review - 2016

Summary

Global Markets Direct’s, ‘GP Pharm, S.A. - Product Pipeline Review - 2016’, provides an overview of the GP Pharm, S.A.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by GP Pharm, S.A., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note:*:Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of GP Pharm, S.A.
  • The report provides overview of GP Pharm, S.A. including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses GP Pharm, S.A.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features GP Pharm, S.A.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
Reasons to buy
  • Evaluate GP Pharm, S.A.’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for GP Pharm, S.A.
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding GP Pharm, S.A.’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope


GP Pharm, S.A. Snapshot
GP Pharm, S.A. Overview
Key Facts
GP Pharm, S.A. - Research and Development Overview
Key Therapeutic Areas
GP Pharm, S.A. - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
GP Pharm, S.A. - Pipeline Products Glance
GP Pharm, S.A. - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
GP Pharm, S.A. - Drug Profiles
leuprolide acetate - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
octreotide acetate MAR - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Pegylated Doxorubicin - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
risperidone depot - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
GP Pharm, S.A. - Pipeline Analysis
GP Pharm, S.A. - Pipeline Products by Target
GP Pharm, S.A. - Pipeline Products by Route of Administration
GP Pharm, S.A. - Pipeline Products by Molecule Type
GP Pharm, S.A. - Pipeline Products by Mechanism of Action
GP Pharm, S.A. - Dormant Projects
GP Pharm, S.A. - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer
List of Tables
GP Pharm, S.A., Key Facts
GP Pharm, S.A. - Pipeline by Indication, 2016
GP Pharm, S.A. - Pipeline by Stage of Development, 2016
GP Pharm, S.A. - Monotherapy Products in Pipeline, 2016
GP Pharm, S.A. - Preclinical, 2016
GP Pharm, S.A. - Pipeline by Target, 2016
GP Pharm, S.A. - Pipeline by Route of Administration, 2016
GP Pharm, S.A. - Pipeline by Molecule Type, 2016
GP Pharm, S.A. - Pipeline Products by Mechanism of Action, 2016
GP Pharm, S.A. - Dormant Developmental Projects,2016
GP Pharm, S.A., Other Locations
List of Figures
GP Pharm, S.A. - Pipeline by Indication, 2016
GP Pharm, S.A. - Pipeline by Target, 2016
GP Pharm, S.A. - Pipeline by Route of Administration, 2016
GP Pharm, S.A. - Pipeline by Molecule Type, 2016
GP Pharm, S.A. - Pipeline Products by Mechanism of Action, 2016

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report